Product nameAnti-VSTM2B antibody [EPR10949]
DescriptionRabbit monoclonal [EPR10949] to VSTM2B
Tested applicationsSuitable for: WB, IPmore details
Unsuitable for: ICC or IHC-P
Species reactivityReacts with: Mouse, Rat, Human
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human VSTM2B aa 250 to the C-terminus (Cysteine residue). The exact sequence is proprietary.
Database link: A6NLU5
- Fetal brain and Human hypothalamus lysates.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab174299 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Predicted molecular weight: 30 kDa.|
|IP||1/10 - 1/100.|
RelevanceContains 1 Ig-like V-type (immunoglobulin-like) domain.
Cellular localizationMembrane; Single-pass type I membrane protein
- V set and transmembrane domain containing 2B antibody
- V-set and transmembrane domain-containing protein 2B antibody
- VSTM2B antibody
All lanes : Anti-VSTM2B antibody [EPR10949] (ab174299) at 1/1000 dilution
Lane 1 : Fetal brain lysate
Lane 2 : Human hypothalamus lysate
Lysates/proteins at 10 µg per lane.
Predicted band size: 30 kDa
Western blot analysis on immunoprecipitation pellet from (1) fetal brain lysate or (2) 1X PBS (negative control) using ab174299 and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
ab174299 has not yet been referenced specifically in any publications.